The effects of intra-rectal and intra-peritoneal application of Origanum onites L. essential oil on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in the rat
Göster/ Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2008Yazar
Dundar, EmineOlgun, Esra Gurlek
Isiksoy, Serap
Kürkçüoğlu, Mine
Başer, K. Hüsnü Can
Bal, Cengiz
Üst veri
Tüm öğe kaydını gösterÖzet
The aim of the present study is to investigate the treatment efficiency of intra-rectal (IR) and intra-peritoneal (W) application of Origanum onites essential oil (OOEO), which is a well-known antioxidant, in the colitis model induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) and ethanol (E) in comparison with dexamethasone therapy through the morphologic damage score. Monoclonal antibodies against intercellular adhesion molecule-1 (ICAM-1, CD54), antirat granulocytes, and myeloperoxidase (MPO), were also investigated immunohistochemically. There was a significant difference in terms of ulceration, mucus cell depletion, inflammatory cell infiltration, vascular dilatation (P < 0.001), crypt abscesses (p < 0.01), and edema (p < 0.05) between OOEO-1 mg/kg-IR and control colitis groups. A significant difference was encountered in terms of mucus cell depletion, crypt abscesses, inflammatory cell infiltration, vascular dilatation (p < 0.01), and ulceration (p < 0.05) between the OOEO-0.1 mg/kg-IR and control colitis groups. A significant difference was noticed in terms of ulceration, inflammatory cell infiltration, mucus cell depletion (P < 0.001), vascular dilatation (p < 0.01), and mucosal atrophy (p < 0.05) between the OOEO-1 mg/kg-IP and control colitis groups. There was a significant difference in terms of ulceration, mucus cell depletion, inflammatory cell infiltration (p < 0.001), crypt abscesses, vascular dilatation (p < 0.01), and mucosal atrophy (p < 0.05) between the OOEO-0.1 mg/kg-IP and control colitis groups. No significant difference was determined in terms of ulceration, inflammatory cyst, mucosal atrophy, edema, and vascular dilatation between the dexamethazone and control colitis groups (p > 0.05). Under the present conditions, we concluded that IR and IP OOEO treatment, applied at the dosage of 0.1 or 1 mg/kg/day, have a significant protective effect on the colonic injury